155 related articles for article (PubMed ID: 19229136)
1. Mucosal immunity on the banks of the Duoro.
Lavelle EC; Thanavala Y; Ogra P
Hum Vaccin; 2009 May; 5(5):281-3. PubMed ID: 19229136
[TBL] [Abstract][Full Text] [Related]
2. All things mucosal.
Thanavala Y; Lavelle E; Ogra P
Expert Rev Vaccines; 2009 Feb; 8(2):139-42. PubMed ID: 19196192
[TBL] [Abstract][Full Text] [Related]
3. Delivery systems: a vaccine strategy for overcoming mucosal tolerance?
Mann JF; Acevedo R; Campo JD; Pérez O; Ferro VA
Expert Rev Vaccines; 2009 Jan; 8(1):103-12. PubMed ID: 19093777
[TBL] [Abstract][Full Text] [Related]
4. Mucosal immunisation: Successful approaches to targeting different tissues.
Ferro VA; Carter KC
Methods; 2006 Feb; 38(2):61-4. PubMed ID: 16442812
[No Abstract] [Full Text] [Related]
5. Modern mucosal vaccines, adjuvants and microbicides.
Cranage MP; Manoussaka M
Expert Rev Anti Infect Ther; 2009 Feb; 7(1):21-3. PubMed ID: 19622054
[TBL] [Abstract][Full Text] [Related]
6. Advances and challenges in mucosal adjuvant technology.
Newsted D; Fallahi F; Golshani A; Azizi A
Vaccine; 2015 May; 33(21):2399-405. PubMed ID: 25865473
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of local antibody production: parenteral or mucosal vaccination?
Bouvet JP; Decroix N; Pamonsinlapatham P
Trends Immunol; 2002 Apr; 23(4):209-13. PubMed ID: 11923116
[TBL] [Abstract][Full Text] [Related]
8. New insights in mucosal vaccine development.
Pavot V; Rochereau N; Genin C; Verrier B; Paul S
Vaccine; 2012 Jan; 30(2):142-54. PubMed ID: 22085556
[TBL] [Abstract][Full Text] [Related]
9. Vaccine adjuvants: a priority for vaccine research.
Harandi AM; Medaglini D; Shattock RJ;
Vaccine; 2010 Mar; 28(12):2363-6. PubMed ID: 20064476
[TBL] [Abstract][Full Text] [Related]
10. New developments in oral vaccines and mucosal adjuvants.
Subiza JL; El-Qutob D; Fernandez-Caldas E
Recent Pat Inflamm Allergy Drug Discov; 2015; 9(1):4-15. PubMed ID: 25669205
[TBL] [Abstract][Full Text] [Related]
11. Mucosal adjuvants.
Harandi AM; Medaglini D
Curr HIV Res; 2010 Jun; 8(4):330-5. PubMed ID: 20353395
[TBL] [Abstract][Full Text] [Related]
12. Identification of new candidates as mucosal vaccine adjuvant in TNF family cytokines.
Kayamuro H; Yoshioka Y; Abe Y; Katayama K; Arita S; Nomura T; Yoshikawa T; Itoh N; Kamada H; Tsunoda S; Tsutsumi Y
Adv Exp Med Biol; 2011; 691():299-304. PubMed ID: 21153334
[No Abstract] [Full Text] [Related]
13. Intranasal vaccination.
Woodland DL
Viral Immunol; 2013 Apr; 26(2):125. PubMed ID: 23573978
[No Abstract] [Full Text] [Related]
14. Recent progress in mucosal vaccine development: potential and limitations.
Lycke N
Nat Rev Immunol; 2012 Jul; 12(8):592-605. PubMed ID: 22828912
[TBL] [Abstract][Full Text] [Related]
15. New developments in nanoparticle-based vaccination.
Riedmann EM
Hum Vaccin Immunother; 2013 Dec; 9(12):2502. PubMed ID: 24716209
[No Abstract] [Full Text] [Related]
16. Modes of Action for Mucosal Vaccine Adjuvants.
Aoshi T
Viral Immunol; 2017; 30(6):463-470. PubMed ID: 28436755
[TBL] [Abstract][Full Text] [Related]
17. Defending the mucosa: adjuvant and carrier formulations for mucosal immunity.
Lawson LB; Norton EB; Clements JD
Curr Opin Immunol; 2011 Jun; 23(3):414-20. PubMed ID: 21511452
[TBL] [Abstract][Full Text] [Related]
18. Cross-protective immunity against influenza virus infections induced by intranasal vaccination together with a TLR3-mucosal adjuvant.
Ainai A; Tashiro M; Hasegawa H
Hum Vaccin; 2011; 7 Suppl():174-82. PubMed ID: 21321485
[TBL] [Abstract][Full Text] [Related]
19. Intranasal delivery of nanoparticle-based vaccines.
Marasini N; Skwarczynski M; Toth I
Ther Deliv; 2017 Jan; 8(3):151-167. PubMed ID: 28145824
[TBL] [Abstract][Full Text] [Related]
20. Chitosan-based mucosal adjuvants: Sunrise on the ocean.
Xia Y; Fan Q; Hao D; Wu J; Ma G; Su Z
Vaccine; 2015 Nov; 33(44):5997-6010. PubMed ID: 26271831
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
